Clinical Study

A Randomized Phase II Study Of Adjuvant Concurrent Radiation And Chemotherapy Versus Radiation Alone In Resected High-Risk Malignant Salivary Gland Tumor

Posted Date: Dec 23, 2013

  • Investigator: Kevin Redmond
  • Co-Investigator: Kara Evans
  • Specialties: Hematology/Oncology, Oncology, Otolaryngology, Surgical Oncology, Cancer, Head & Neck Cancer
  • Type of Study: Drug

This study will compare the good and bad effects of radiation and chemotherapy with radiation alone on salivary gland cancer to find out which is better at reducing the chance of the cancer returning. Patients with salivary gland cancer are at an increased risk for disease recurrence. This study will test whether patients who receive Cisplatin and radiation following oral surgery for salivary gland cancer have improved results than those who receive radiation only.

Criteria:

Eligible Patients Must Have Cancer Of The Salivary Gland That Has Been Removed By Surgery.

Keywords:

Head And Neck Cancer, Phase Ii, Radiation , Rtog 1008, Salivary Gland

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant